Suppr超能文献

药物对变应性鼻炎患儿鼻分泌物中抗原诱导的高分子量中性粒细胞趋化活性和组胺释放的影响。

Drug effects on antigen-induced release of high molecular weight-neutrophil chemotactic activity and histamine in nasal secretion from children with allergic rhinitis.

作者信息

Onda T, Nagakura T, Uekusa T, Masaki T, Iikura Y

机构信息

Division of Allergy, National Children's Medical Research Center, Tokyo, Japan.

出版信息

Allergy Proc. 1990 Sep-Oct;11(5):235-40. doi: 10.2500/108854190778879837.

Abstract

Five children with allergic rhinitis sensitive to house dust mite as documented by skin test, radioallergosorbent test, score and nasal provocation were studied. Patients were subjected to nasal challenge with 3.125, 6.25, 12.5, and 25 protein nitrogen micrograms per disc of house dust mite antigens and nasal secretions were collected by the filter paper method. Neutrophil chemotactic activity (NCA) and histamine content of the nasal secretions were measured. NCA and histamine were released in a dose- and time-dependent manner, and no significant correlation between NCA and histamine was revealed in each subject. Pretreatment with 5.2 mg of nasal disodium cromoglycate or 0.5 micrograms of nasal adrenaline 5 minutes before provocation totally inhibited mediator release upon nasal challenge with 12.5 micrograms of house dust mite. A dose of 100 micrograms of nasal beclomethasone dipropionate 5 minutes before challenge neither inhibited clinical symptoms nor mediator release; 100 micrograms x 3 times per day of nasal beclomethasone dipropionate for 3 days, however, significantly inhibited clinical symptoms and release of both NCA (p less than 0.05) and histamine (p less than 0.05). NCA eluted as a single peak with an estimated molecular weight of 600,000. These results suggest that high molecular weight-NCA may be involved in the pathogenesis of allergic rhinitis.

摘要

对5名经皮肤试验、放射变应原吸附试验、评分及鼻激发试验证实对屋尘螨过敏的变应性鼻炎患儿进行了研究。让患者用每片含3.125、6.25、12.5和25微克蛋白氮的屋尘螨抗原进行鼻激发试验,并采用滤纸法收集鼻分泌物。测定鼻分泌物中的中性粒细胞趋化活性(NCA)和组胺含量。NCA和组胺呈剂量和时间依赖性释放,且在每个受试者中NCA与组胺之间未显示出显著相关性。激发试验前5分钟用5.2毫克色甘酸钠滴鼻剂或0.5微克肾上腺素滴鼻剂预处理,可完全抑制用12.5微克屋尘螨进行鼻激发试验时介质的释放。激发试验前5分钟给予100微克二丙酸倍氯米松滴鼻剂,既不能抑制临床症状,也不能抑制介质释放;然而,每天3次、每次100微克二丙酸倍氯米松滴鼻,连续3天,可显著抑制临床症状以及NCA(p<0.05)和组胺(p<0.05)的释放。NCA以单一峰洗脱,估计分子量为600,000。这些结果表明,高分子量的NCA可能参与变应性鼻炎的发病机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验